📊 OMDA Key Takeaways
Is Omada Health, Inc. (OMDA) a Good Investment?
Omada Health demonstrates strong revenue growth (53.2% YoY) with exceptional gross margins (62.4%), indicating a sustainable core business model. However, negative operating cash flow (-$11.8M) and operating losses (-$4.8M) indicate the company is not yet executing profitably at scale. The fortress balance sheet ($211.8M cash, zero debt) provides 18-24 months of runway to reach operating breakeven, but trajectory must improve markedly to justify continued cash consumption.
Omada Health is scaling rapidly with 53% YoY revenue growth, a 66% gross margin, and positive free cash flow, indicating a capital-light model with improving unit economics. Losses are modest and narrowing, and a debt-free, cash-rich balance sheet provides ample runway to reach sustained GAAP profitability. Continued execution should translate operating leverage into durable profits while maintaining growth quality.
Omada Health, Inc. Key Strengths (OMDA)
- Outstanding gross margin of 62.4% demonstrates pricing power and efficient delivery of healthcare services
- Strong revenue growth of 53.2% YoY in large addressable healthcare market with improving loss trajectory (-3.0M improving 72.9% YoY)
- Fortress balance sheet with $211.8M cash, zero long-term debt, 3.92x current ratio, and equity of $234.1M provides substantial operational runway
- Debt-free balance sheet with $222M cash and strong liquidity (3.6x current ratio)
- Positive operating and free cash flow with low capex (6.5% FCF margin)
- High gross margin (65.7%) and improving operating leverage near breakeven
OMDA Stock Risks: Omada Health, Inc. Investment Risks
- Negative operating cash flow of -$11.8M indicates company is burning cash operationally despite gross profitability—unsustainable if not corrected within 12-18 months
- Operating margin of -6.1% with $4.8M operating losses suggests operating expenses are growing faster than revenue, indicating poor operating leverage
- Cash depletion trajectory at current burn rate of approximately $11.8M annually would exhaust reserves within 18+ years, but path to positive OCF must be demonstrated soon
- Potential revenue growth deceleration as scale increases
- Regulatory/reimbursement and payer contract risks affecting revenue visibility
- Competitive digital health market and possible customer concentration pressuring margins/retention
Key Metrics to Watch
- Operating cash flow trend - critical inflection point toward positive OCF
- Operating expense ratio as percentage of revenue - must show operating leverage and expense discipline
- Revenue growth sustainability and contribution margin trends by customer segment
- Operating margin (sustained positive, >5%)
- Revenue growth YoY (sustainability >25%)
Omada Health, Inc. (OMDA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 3.92x current ratio provides a solid financial cushion.
OMDA Profit Margin, ROE & Profitability Analysis
OMDA vs Services Sector: How Omada Health, Inc. Compares
How Omada Health, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Omada Health, Inc. Stock Overvalued? OMDA Valuation Analysis 2026
Based on fundamental analysis, Omada Health, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Omada Health, Inc. Balance Sheet: OMDA Debt, Cash & Liquidity
OMDA Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Omada Health, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-9.52 indicates the company is currently unprofitable.
OMDA Revenue Growth, EPS Growth & YoY Performance
OMDA Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $55.0M | -$3.0M | $-0.05 |
| Q3 2025 | $45.5M | -$3.2M | $-0.06 |
| Q2 2025 | $41.2M | -$5.3M | $-0.24 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Omada Health, Inc. Dividends, Buybacks & Capital Allocation
OMDA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Omada Health, Inc. (CIK: 0001611115)
📋 Recent SEC Filings
❓ Frequently Asked Questions about OMDA
What is the AI rating for OMDA?
Omada Health, Inc. (OMDA) has a Combined AI Grade of A from Claude (B) and ChatGPT (A) with 80% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are OMDA's key strengths?
Claude: Outstanding gross margin of 62.4% demonstrates pricing power and efficient delivery of healthcare services. Strong revenue growth of 53.2% YoY in large addressable healthcare market with improving loss trajectory (-3.0M improving 72.9% YoY). ChatGPT: Debt-free balance sheet with $222M cash and strong liquidity (3.6x current ratio). Positive operating and free cash flow with low capex (6.5% FCF margin).
What are the risks of investing in OMDA?
Claude: Negative operating cash flow of -$11.8M indicates company is burning cash operationally despite gross profitability—unsustainable if not corrected within 12-18 months. Operating margin of -6.1% with $4.8M operating losses suggests operating expenses are growing faster than revenue, indicating poor operating leverage. ChatGPT: Potential revenue growth deceleration as scale increases. Regulatory/reimbursement and payer contract risks affecting revenue visibility.
What is OMDA's revenue and growth?
Omada Health, Inc. reported revenue of $78.0M.
Does OMDA pay dividends?
Omada Health, Inc. does not currently pay dividends.
Where can I find OMDA SEC filings?
Official SEC filings for Omada Health, Inc. (CIK: 0001611115) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is OMDA's EPS?
Omada Health, Inc. has a diluted EPS of $-0.05.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is OMDA's fundamental grade?
Based on our AI fundamental analysis in May 2026, Omada Health, Inc. has a A grade with 80% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is OMDA stock overvalued or undervalued?
Valuation metrics for OMDA: ROE of -1.3% (sector avg: 16%), net margin of -3.8% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is OMDA's AI grade for 2026?
Our dual AI analysis gives Omada Health, Inc. a combined A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is OMDA's free cash flow?
Omada Health, Inc.'s operating cash flow is $-11.8M, with capital expenditures of $78.0K. FCF margin is -15.3%.
How does OMDA compare to other Services stocks?
Vs Services sector averages: Net margin -3.8% (avg: 10%), ROE -1.3% (avg: 16%), current ratio 3.92 (avg: 1.5).